Related Experiment Videos
Streptococcal toxic shock syndrome in children
1Unité de Réanimation Pédiatrique, Hopital Edouard Herriot, Lyon, France.
Intensive Care Medicine
|January 1, 1992
Summary
Two children developed toxic shock-like syndrome from Streptococcus pyogenes infections. Strains producing erythrogenic toxin B, not A, were implicated, suggesting regional differences in toxin involvement.
Area of Science:
- Microbiology
- Infectious Diseases
- Toxicology
Background:
- Toxic shock-like syndrome (TSLS) is a severe condition often associated with bacterial toxins.
- Group A Streptococcus (GAS) is a known pathogen capable of causing TSLS.
- Erythrogenic toxins (ETs) produced by GAS are implicated in the pathogenesis of TSLS.
Observation:
- Two pediatric cases of TSLS secondary to soft tissue streptococcal infections are presented.
- One of the two cases was fatal.
- Blood cultures identified Streptococcus pyogenes in both children.
Findings:
- The isolated Streptococcus pyogenes strains produced significant quantities of erythrogenic toxin B (ET B) and smaller amounts of ET C.
- Notably, these strains did not produce erythrogenic toxin A (ET A).
- This contrasts with many reported US cases where ET A is considered the primary toxin.
Implications:
- This study reinforces the role of Streptococcus pyogenes in TSLS.
- The findings suggest that strains producing high levels of ET B may be more prevalent in TSLS cases observed in Europe.
- Understanding regional variations in ET production is crucial for accurate diagnosis and treatment of streptococcal TSLS.